Development of the Harvey-Bradshaw Index-pro (HBI-PRO) Score to Assess Endoscopic Disease Activity in Crohn's Disease.

about

Development of the Harvey-Bradshaw Index-pro (HBI-PRO) Score to Assess Endoscopic Disease Activity in Crohn's Disease.

Item

http://www.wikidata.org/entity/Q51029746

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Development of the Harvey-Brad ...... e Activity in Crohn's Disease.

@en

Development of the Harvey-Bradshaw Index-pro

@nl

type

Item

label

Development of the Harvey-Brad ...... e Activity in Crohn's Disease.

@en

Development of the Harvey-Bradshaw Index-pro

@nl

prefLabel

Development of the Harvey-Brad ...... e Activity in Crohn's Disease.

@en

Development of the Harvey-Bradshaw Index-pro

@nl

P1476

Development of the Harvey-Brad ...... e Activity in Crohn's Disease.

@en

P2093

A Hillary Steinhart

http://www.w3.org/2001/XMLSchema#string

Boyko Kabakchiev

http://www.w3.org/2001/XMLSchema#string

Geoffrey C Nguyen

http://www.w3.org/2001/XMLSchema#string

Kenneth Croitoru

http://www.w3.org/2001/XMLSchema#string

Mark S Silverberg

http://www.w3.org/2001/XMLSchema#string

Orlaith B Kelly

http://www.w3.org/2001/XMLSchema#string

Raquel Milgrom

http://www.w3.org/2001/XMLSchema#string

P2860

How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?

A simple index of Crohn's-disease activity

Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial.

Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-control questionnaire

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.

Are activity indices helpful in assessing active intestinal inflammation in Crohn's disease?

Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health

Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients.

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

P304

543-548

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ECCO-JCC/JJW200

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eran Zittan

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28453763

http://www.w3.org/2001/XMLSchema#string